The Alaska Kidney Foundation will accept 2020 proposal requests from October 23rd, 2019 – December 6th, 2019.
Alaska Kidney Foundation began in 1973 operating the first dialysis centers in Anchorage and Fairbanks. In 1999 both dialysis centers were sold to Renal Care Group and proceeds were used to establish the Alaska Kidney Foundation as a charitable philanthropic grant making organization. Foundation leadership includes nine Board of Directors and medical adviser.
Kidney Disease in Alaska
Kidney disease impacts millions of people worldwide. In the United States one in 10 adults, more than 20 million, have some form of chronic kidney disease. In Alaska there are over 500 people on dialysis and that number is steadily increasing. Diabetes is the leading primary diagnosis for end stage renal disease. The American Diabetes Association reports that 68,500 Alaskans are affected by diabetes.
According to the United Network for Organ Sharing there are hundreds of Alaskans waiting for a transplant. According to the Northwest Renal Network, “Alaska is 2000 miles from the lower 48 states, upon which it depends for a number of specialized healthcare services including renal transplantation. Travel between the more widely dispersed communities is by air or sea”. Due in part to the many remote areas of the State, Alaskans with chronic kidney disease, especially those new to dialysis, and those waiting for transplant, may be at a significantly higher risk for financial hardship.
The mission of the Alaska Kidney Foundation is to wisely use it resources to help Alaskans with or at risk of kidney disease.
* Respect * Compassion * Responsiveness * Accountability
The Alaska Kidney Foundation does not discriminate in its grant making on any basis including race, gender, religion, ethnicity, creed, marital status, sexual orientation, age, disability.
Alaska Kidney Foundation is committed to granting funds to organizations that are addressing the causes and treatments of kidney disease in Alaska, and supporting Alaskan residents with, or at risk of kidney disease. Grants may be awarded to individuals, and for special projects, programs, or general operating support for established organizations.
- Alaskans with kidney disease will have emergency relief for basic human needs.
- Alaskans with kidney disease will have timely kidney transplants and donations for all organs will be increased.
- Alaskans at risk of kidney disease will have early screening.
- Alaskans will be educated on the importance of preventing kidney disease.
- Alaskans with kidney disease will be knowledgeable and empowered health care consumers.
2020 Request for Proposal – Instruction Summary
- Submission Deadline for 2020 is by e-mail on/or before December 6, 2019.
- Grant award amounts range from $5,000 to $50,000. Average is $10,000 to $25,000.
- Eligible activities must specifically address one or more of the goals of AKF.
- Examples of organizations awarded grants in the past include Alaska Health Fair, Alaska Kidney Patients Assoc; American Diabetes Assoc-Alaska, Life Alaska, and Healthy Futures.
- Eligible organizations have tax exempt status under section 501(c)3 of the Internal Revenue Service code, or procurement for services arrangement with established organizations that do not qualify as 501(c)3, but provide a service which is compatible with our goals.
- Allowable grant expenses include all costs normally associated with the activities of the project including personnel services, transportation, facility expenses, supplies, equipment, printing etc. An administrative cost of no more than 15% may be charged to the grant.
- Eligible beneficiaries of project outcomes must be Alaskans with or at risk of kidney disease. Alaskans out of State for treatment are eligible beneficiaries.
- Public recognition of AKF is not a requirement from grant award recipients; however, when and if public recognition is appropriate, AKF must approve the copy.
- Grant application review process is completed by a nine member volunteer committee consisting of former AKF board members and a medical adviser.
- Response character limitations are specified. Please be concise. Short and succinct is appreciated.
For more information, please contact ACF staff at:
(907) 334-6700 or email@example.com